LENSAR, Inc.
LENSAR, Inc. (LNSR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LNSR · as of Jun 8, 2026
Key Statistics
Explore LENSAR, Inc. Data
lnsr stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 66.7%
The LNSR analyst consensus is Buy, based on ratings from 3 Wall Street analysts over the past 3 months. The average 12-month price target is $10.00, representing +80.94% upside from the current price of $5.53.
Competitors & Peers
lnsr competitorsLNSR
ANIK
ARAY
AVR
CRBP
CRDFStock Performance
Full HistoryAbout LENSAR, Inc.
LENSAR, Inc. a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or…
what is lensar, inc. · lnsr stock overview · lensar, inc. company profile · who is lensar, inc. ceo · lnsr NASDAQ · lensar, inc. headquarters · lensar, inc. business segments
About Stock Overview & Key Data
LENSAR, Inc. (LNSR) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Oct 2, 2020. As of the latest trading session, LNSR stock price is $5.53, with a market capitalization of $67.7M. The stock has returned -57.30% over the past 12 months and -51.93% year-to-date.
According to 3 Wall Street analysts, the consensus rating for LENSAR, Inc. stock is Buy, with an average 12-month price target of $10.00. In fiscal year 2025, LENSAR, Inc. reported revenue of $58.4M and net income of -$34.3M. For detailed data — including LENSAR, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, LENSAR, Inc. (LNSR) stock price is $5.53. The stock is traded on NASDAQ under the ticker symbol LNSR. The 52-week range is $5.06 – $13.67.